6533b82efe1ef96bd1293457

RESEARCH PRODUCT

Betatrophin Levels Are Related to the Early Histological Findings in Nonalcoholic Fatty Liver Disease

T. DogruHasan GurelAli Fuat ÇIçekRizzo ManfrediAlper SonmezHalil GencCemal Nuri ErçinSerkan TapanAli KirikCem HaymanaGurkan CelebiCem Barçın

subject

nonalcoholic fatty liver disease0301 basic medicinemedicine.medical_specialtyBetatrophinEndocrinology Diabetes and Metabolismmedicine.medical_treatmentbetatrophin030209 endocrinology & metabolismMicrobiologydigestive systemBiochemistryArticle03 medical and health scienceschemistry.chemical_compound0302 clinical medicineInsulin resistanceinsulin resistanceInternal medicineNonalcoholic fatty liver diseaseMedicineMolecular BiologyBetatrophin Glucose intolerance Insulin resistance Nonalcoholic fatty liver diseaseTriglyceridebusiness.industryInsulinnutritional and metabolic diseasesLipid metabolismmedicine.diseaseQR1-502digestive system diseases030104 developmental biologyEndocrinologyglucose intolerancechemistrySteatosisbusinessHormone

description

Betatrophin, a liver hormone, regulates glucose and lipid metabolism. We investigated the betatrophin levels in nonalcoholic fatty liver disease (NAFLD) and searched for any relationship with histological severity and metabolic parameters. Fifty males with NAFLD [Nonalcoholic Steatohepatitis (NASH) (n = 32)

yearjournalcountryeditionlanguage
2021-06-28Metabolites
https://doi.org/10.3390/metabo11070425